Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Currently, it is only FDA-approved for the treatment of type 2 diabetes, but is being studied for the treatment of obesity, as it was seen to cause significant weight loss
Tirzepatide (Mounjaro) Technically a dual GIP/GLP-1 receptor agonist, meaning it targets two incretin hormones rather than one
Y., Xu, X
BuonocoreDGrosiniMGiardinaSMichelottiACarrabettaMSeneciAet al
Consider starting keto at least four to six weeks before beginning GLP-1, or conversely, becoming fully adapted to your GLP-1 medication before introducing carbohydrate restriction
US$ 23.81
US$ 25.66
US$ 21.66
US$ 24.99
US$ 27.90
US$ 27.78
US$ 25.44
US$ 25.13
